Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy

被引：51

作者：

Penz, M ^{[1
]}

Kornek, GV ^{[1
]}

Raderer, M ^{[1
]}

Ulrich-Pur, H ^{[1
]}

Fiebiger, W ^{[1
]}

Scheithauer, W ^{[1
]}

机构：

[1] Univ Vienna, Sch Med, Dept Internal Med 1, Div Oncol, A-1010 Vienna, Austria

来源：

ANNALS OF ONCOLOGY | 2001年 / 12卷 / 03期

关键词：

D O I：

10.1023/A:1011184609963

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：421 / 422

页数：2

共 8 条

[1]

Cvitkovic E, 1999, SEMIN ONCOL, V26, P647

[2] American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants [J].

Hensley, ML ;

Schuchter, LM ;

Lindley, C ;

Meropol, NJ ;

Cohen, GI ;

Broder, G ;

Gradishar, WJ ;

Green, DM ;

Langdon, RJ ;

Mitchell, B ;

Negrin, R ;

Szatrowski, TP ;

Thigpen, JT ;

Von Hoff, D ;

Wasserman, TH ;

Winer, EP ;

Pfister, DG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3333-3355

[3] Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study [J].

Koukourakis, MI ;

Kyrias, G ;

Kakolyris, S ;

Kouroussis, C ;

Frangiadaki, C ;

Giatromanolaki, A ;

Retalis, G ;

Georgoulias, V .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2226-2233

[4]

Mariani G, 2000, P AN M AM SOC CLIN, V19, p609a

[5] Oxaliplatin in practice [J].

Misset, JL .

BRITISH JOURNAL OF CANCER, 1998, 77 (Suppl 4) :4-7

[6] Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer [J].

Scheithauer, W ;

Kornek, GV ;

Raderer, M ;

Valencak, J ;

Weinländer, G ;

Hejna, M ;

Haider, K ;

Kwasny, W ;

Depisch, D .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :902-906

[7]

SCHEITHAUER W, 2000, P AN M AM SOC CLIN, V19, pA257

[8]

SHAW L, 1997, P AN M AM SOC CLIN, V16, pA250

← 1 →